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Abstract The potential application of polysaccharide-based
films containing smart nanohydrogels for the controlled re-
lease of food preservatives is demonstrated here. Smart active
packaging is the most promising alternative to traditional
packaging as it provides a controlled antimicrobial effect,
which allows reducing the amount of preservatives in the food
bulk, releasing them only on demand. This work evaluates the
u s e f u l n e s s o f sma r t t h e rmos en s i t i v e po l y (N -
isopropylacrylamide) (PNIPA) nanohydrogels with or without
acrylic acid (AA) incorporated into polysaccharide-based
films (GA) to transport natamycin and release it as a response
to environmental triggers. Release kinetics in liquid medium
from GA films containing PNIPA/AA nanohydrogels (GA-
PNIPA(5) and GA-PNIPA-20AA(5)) presented a characteris-
tic feature regarding the films without nanohydrogels that was
the appearance of a lag time in natamycin release, able to
reach values of around 35 h. Another important feature of
natamycin release kinetics was the fact that the release from
GA-PNIPA/AA films only occurred when temperature was
increased, so that the natamycin release was restricted to when
there is a risk of growth of microorganisms that cause food
spoilage or the development of pathogenic microorganisms.
Additionally, it could be observed that the relative fraction of
natamycin released from GA-PNIPA/AA films was signifi-
cantly (p<0.05) higher than that released from GA films
loaded with the same amount of free natamycin. It can be
hypothesised that the encapsulation of natamycin into
nanohydrogels helped it to be released from GA films, creat-
ing reservoirs of natamycin into the films and, therefore, fa-
cilitating its diffusion through the film matrix when the
nanohydrogel collapses. In a solid medium, the low water
availability limited natamycin release from GA-PNIPA/AA
films restricting the on/off release mechanism of PNIPA/AA
nanohydrogels and favouring the hydrophobic interactions
between natamycin and polymer chains at high temperatures.
Despite the low natamycin release in solid media, antimicro-
bial efficiency of GA-PNIPA(5) films containing natamycin in
acidified agar plates was higher than that obtained with GA
films without natamycin and GA films with free natamycin,
probably due to the protecting effect against degradation when
natamycin was included in the nanohydrogels, allowing its
release only when the temperature increased.
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hexaoleate
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released from films
towards agar plates
GA-NA GA films containing free natamycin
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GA-PNIPA-
20AA(5)
Polysaccharide-based
films containing PNIPA-20AA(5)
nanohydrogel
GA-PNIPA-
20AA(5)+NA(8)
GA films containing
PNIPA-20AA(5) nanohydrogels
loaded with 7.92 μg of natamycin
GA-PNIPA(5) Polysaccharide-based
films containing PNIPA(5)
nanohydrogel
GA-
PNIPA(5)+NA(8)
GA films containing
PNIPA(5) nanohydrogels loaded
with 7.92 μg of natamycin
GA-PNIPA/AA Polysaccharide-based
films containing poly
(N-isopropylacrylamide)
nanohydrogel with or
without copolymerised acrylic acid
GA Polysaccharide-based films
GA+NA(564) GA films containing 564.24 μg
of free natamycin
GA+NA(8) GA films containing
7.92 μg of free natamycin
IsoparTM M Isoparaffinic synthetic hydrocarbon
LCST Lower critical solution temperature
MIC Minimum inhibitory
concentrations
n The diffusional exponent
that depends on both the
geometry of the delivery
system and the physical
mechanisms involved
NIPA N-isopropylacrylamide
NMBA N,N′-methylenebisacrylamide
OP Oil phase
P 1.01 Penicillium commune
PDA Potato dextrose agar
PNIPA-20AA(5) Poly(N-isopropylacrylamide)
nanohydrogel copolymerised
with 20 % (w/w) of acrylic
acid using 5 % (w/w) of
crosslinking
PNIPA Poly(N-isopropylacrylamide)
PNIPA(5) Poly(N-isopropylacrylamide)
nanohydrogel with 5 %
(w/w) of crosslinking
PNIPA/AA Poly(N-isopropylacrylamide)
nanohydrogel with or without
copolymerised acrylic acid
RP-HPLC Reverse phase
high-performance liquid
chromatography
Sc 1.02 Saccharomyces cerevisiae
SpanTM 83 Sorbitan sesquiolate
ST Surfactant
vmax Maximum release rate (h
−1)
γFmax Maximum relative
fraction of natamycin
released from films
γFt Relative fraction of
natamycin released from films
λ The lag time for the natamycin
release, expressed in hours (h)
Introduction
In recent years, considerable importance has been given to the
development of new materials for food packaging applica-
tions. One of the main objectives in the food industry is to
replace the traditional food packaging, designed to protect
food against the effects of the environment (e.g. microorgan-
isms, oxygen, off-odours and light), where the key safety ob-
jective is for it to be as inert as possible (i.e. there should be a
minimum of interaction between the food and the packaging)
(Dainelli et al. 2008) bymultifunctional packaging (e.g. active
and smart packaging) (Han 2005; Han et al. 2005; Rooney
2005). The most innovative developments in the area of food
packaging propose a multifunctional packaging based on the
interaction between the package materials, the food and the
environment, leading to a dynamic role in food preservation
and quality and consumers safety (Brody et al. 2008; Dainelli
et al. 2008). This group of multifunctional packaging can
comprise two types of packaging: (a) active packaging with
the purpose of extending the shelf life of food whilst main-
taining (or even improving) its quality (Vermeiren et al. 1999)
and (b) smart packaging which responds to environmental
conditions (e.g. temperature and pH) increasing food protec-
tion (e.g. by releasing an antimicrobial) or alerting the con-
sumers to contamination and/or the presence of pathogens
(Sekhon 2010).
Natamycin (pimaricin) is a polyene antifungal compound
produced by Streptomyces natalensis and related species. It
was approved as Generally Recognised As Safe (GRAS) by
the Food and Drug Administration (FDA) in the USA and as a
natural preservative in the European Union (E235). It is large-
ly used in the food industry as a preservative on the surface of
cheese, fruit and other non-sterile products, such as meat and
sausages (Farid et al. 2000; Vanden Bossche et al. 2003).
However, natamycin presents some technological problems
associated with its use as food preservative: low solubility in
water and low chemical stability in acidic conditions and un-
der light radiation (Koontz et al. 2003; Stark and Tan 2003).
In previous works (Fuciños et al. 2012; Fuciños et al.
2014b), the limitations of active packaging systems for food
applications have been addressed. Most of these active pack-
aging systems include passive diffusion systems (Türe et al.
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2009; Fajardo et al. 2010; Hanušová et al. 2010; Bierhalz et al.
2012) in which an antimicrobial compound release is con-
trolled by the concentration difference between the food, the
surrounding medium and packaging materials, thus resulting
in an uncontrolled release of antimicrobial compounds. In
Fuciños et al. (2012, 2014b), the use of smart poly(N-
isopropylacrylamide) (PNIPA) nanohydrogels has been pro-
posed as an alternative to passive diffusion mechanism, which
allows a controlled release of bioactive molecules (i.e.
natamycin) as a response to environmental changes (temper-
ature and/or pH). Thus, the amount of preservative in the food
could be reduced. These smart PNIPA nanohydrogels have a
hydrophilic/hydrophobic balance in the side chains that allows
the formation of hydrogen bonds between water molecules
and hydrophilic groups of the hydrogel. Below its lower crit-
ical solution temperature (LCST), nanohydrogels remain sol-
uble and swelled and, in this state, can be loaded with preser-
vative. The value of LCST for PNIPA polymers is around
33 °C (Schild 1992; Zhang et al. 2002; Schmaljohann
2006). When the temperature increases above the LCST, the
hydrophobic groups are strengthened dramatically leading to
the collapse of the polymer chains (Schild 1992; Zhang et al.
2002; Cordeiro et al. 2009; Fuciños et al. 2014a), and the
release of the preservative occurs. By varying the composition
of PNIPA nanohydrogels, it is possible to easily modulate the
polymer collapse pattern. Fuciños et al. (2014a) showed how
the copolymerisation of PNIPAwith acrylic acid (AA) imparts
different structural properties to nanohydrogels affecting the
particle size and swelling capacity. In the same manner,
natamycin release kinetics were very different, depending on
the nanohydrogel composition (Fuciños et al. 2014b). PNIPA
nanohydrogel copolymerised with AA allowed a slower but
more continuous release of natamycin. Thus, the antimicrobial
efficiency of natamycin was improved when encapsulated in
PNIPA/AA nanohydrogels due to the protection that the
nanohydrogel gives against environmental degradation whilst
also lowering the presence of preservatives in food bulk
(Fuciños et al. 2012). But to apply them to the food surface,
a carrier or support of loaded nanoparticles such as an edible
film or a coating may be helpful.
Considering food packaging as one of the main poten-
tial applications of these smart nanohydrogels, in
Cerqueira et al. (2014), natamycin-loaded nanohydrogels
were successfully incorporated into polysaccharide-based
films without influencing their main physical properties.
So it seems that this packaging system could allow im-
proving by, on the one hand, applying active agents onto
the food surface by film formation and, on the other hand,
by achieving a controlled release of the preservative only
when it is necessary, due to nanohydrogel behaviour under
temperature changes.
In this work, natamycin release kinetics from nanohydrogels
incorporated into polysaccharide-based films (GA-PNIPA/AA)
were evaluated, under different temperatures and media, in free
state or when encapsulated in nanohydrogels. Additionally, the
antimicrobial efficiency of these new active and smart films
was assessed in a food model system.
Materials and Methods
Preparation of Natamycin-Loaded PNIPA/AA
Nanohydrogels
The synthesis of PNIPA/AA nanohydrogels and the prepara-
tion of natamycin-loaded PNIPA/AA nanohydrogels were
performed as presented by Fuciños et al. (2012). For the syn-
thesis of nanohydrogels, a water in oil (W/O) microemulsion
formed by 58 % (w/w) of aqueous phase (AP—80 %, w/w,
water and 20 %, w/w, monomer), 17 % (w/w) of oil phase
(OP—isoparaffinic synthetic hydrocarbon: IsoparTM, 98 %,
v/v, Quimidroga, S.A., Barcelona, Spain) and 25 % (w/w) of
surfactant (ST—PEG-40 sorbitol hexaoleate: AtlasTMG-1086
and sorbitan sesquiolate: SpanTM 83, Croda Ibérica, S.A.,
Barcelona, Spain) was prepared. For pure PNIPA
nanohydrogels (PNIPA(5)), the ratio (w /w) of N-
isopropylacrylamide (NIPA, 99 %, w/w, Acros Organics,
Geel, Belgium) based on the monomers (mNIPA/mmonomer)
was 1. For NIPA copolymerised with AA (stabilised with
hydroquinone monomethyl ether, for synthesis, Merck,
Darmstadt, Germany) (PNIPA-20AA(5)) nanohydrogels,
mNIPA/mmonomer was 0.80 and mAA/mmonomer was 0.20. To
preserve the shape and size of the particles during handling,
we used the N,N′-methylenebisacrylamide (NMBA)
crosslinking agent for synthesis (Merck, Darmstadt,
Germany) at a ratio mNMBA/mmonomer=0.05.
The phases (AP and OP) were solubilised and mixed in a
100-mL reactor equipped with mechanical stirring and
thermostatised at 25 °C. The reaction medium was purged
by bubbling nitrogen to eliminate oxygen. Polymerisation
was triggered by adding the initiator (NaHSO3 for analysis,
Merck, Darmstadt, Germany) at a ratio mNaHSO3/mmonomer=
0.01 and monitored by the temperature increase inside the
glass reactor. Chloroform (Panreac, Barcelona, Spain) was
used to selectively precipitate inverse micelles formed during
microemulsion, which contain synthesised nanoparticles. This
mixture was poured over diethyl ether (Panreac, Barcelona,
Spain) to dissolve and remove any residual impurities. The
pure polymer was separated from diethyl ether by decantation
and then it was dried overnight in an oven (50 °C) and then
ground in a colloid mill (IKA-Werke GmbH & Co. KG,
Staufen, Germany).
Natamycin-loaded PNIPA/AA nanohydrogels were pre-
pared by dispersing, with agitation, the PNIPA/AA
nanohydrogel powder in distilled water for 3 h at room tem-
perature to allow the nanoparticles to swell properly. This
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suspension was then mixed with a natamycin (50 % (w/w)
lactose, VGP Pharmachem, Barcelona, Spain) water solution
to obtain final concentrations of 12.5 mg mL−1 of
nanohydrogel and 0.4 mg of commercial natamycin powder
per mL (21.93 μg mL−1 of solubilised pure natamycin). The
mixture was then stirred for 12 h at 25 °C to guarantee the
incorporation of natamycin into the nanohydrogel particles
(Fuciños et al. 2014b).
Preparation of Natamycin-Loaded PNIPA/AA
Nanohydrogels Incorporated into κ-Carrageenan
and Locust Bean Gum (GA) Films
Polysaccharide film-forming solutions were prepared as de-
scribed in Cerqueira et al. (2014). Briefly, 0.4 and 0.6 % (w/v)
of κ-carrageenan (Gelcarin DX5253, FMC Biopolymer,
Norway) and locust bean gum (Genu gum type RL-200, CP
Kelco, USA), respectively, were suspended in distilled water
under agitation during 1 h at 25 °C, after which 0.3 % (w/v) of
glycerol (87 %, v/v, Panreac, Spain) was added to the solution.
Then, the film-forming solutions were homogenised at 80 °C
under agitation during 30 min. Natamycin and the natamycin-
loaded PNIPA/AA nanohydrogels were added after the de-
crease of the temperature to 30 °C in order to avoid the
nanohydrogel collapse.
Two different concentrations of free natamycin were eval-
uated: 500 μg mL−1, based on the published work by Fajardo
et al. (2010), and 21.93 μg mL−1, based on the concentration
of solubilised pure natamycin charged into the nanohydrogels.
Based on these concentrations and assuming that natamycin
was distributed uniformly in the film, the final amount of
natamycin in the films (with 35 mm of diameter) was estimat-
ed to be 564.24 and 7.92 μg, respectively (films prepared with
free natamycin). These films are mentioned as GA+NA(564)
and GA+NA(8), respectively. Natamycin-loaded
nanohydrogels, prepared as explained in the section
BPrepa r a t i on o f Na tamyc in -Loaded PNIPA/AA
Nanohydrogels^, were added to films to a final concentration
of 0.2 % (v/v). The final amount of natamycin in each film
with 35 mm of diameter was estimated to be 7.92 μg. These
films are mentioned as GA-PNIPA(5)+NA(8) and GA-
PNIPA-20AA(5)+NA(8) for the two different nanohydrogels
used in this work.
The compounds were added and stirred until a homoge-
neous solution was obtained. Then, 28 mL of solution was
cast into polystyrene Petri dishes and dried at 25 °C during
48 h, resulting in films with 0.045±0.002 mm of thickness. In
the same manner, films without the incorporation of any com-
pound were prepared and used as control and mentioned as
GA films. All films were conditioned in desiccators contain-
ing a saturated solution of Mg(NO3)2⋅6H2O at 53 % relative
humidity (RH) and 20 °C.
Natamycin Release from PNIPA/AA Nanohydrogels
Incorporated into GA Films
Liquid Medium
The procedure for studying the natamycin release from
nanohydrogels in a liquid medium was based on that de-
scribed in Fuciños et al. (2012). GA films with 35 mm diam-
eter submerged in 3 mL of distilled water were placed in a
dialysis membrane (MWCO 3500 g mol−1, SnakeSkinTM,
Pierce, Rockford, IL, USA) and dialyzed against 12 mL of
distilled water at 10 and 37 °C, with constant stirring. Samples
of 1 mL were taken at intervals from the solution in order to
determine the natamycin concentration. The volume removed
from the probe was returned after measurements had been
made in order to maintain a constant volume. Two replicates
of each film were evaluated for each temperature.
In order to evaluate natamycin availability in the liquid
medium, a control experiment was performed, quantifying
natamycin amount in distilled water, initially added with an
aqueous solutions of commercial natamycin (with the same
amounts of natamycin employed to be incorporated into the
films), and incubated at 10 and 37 °C (below and above,
respectively, the LCST of nanohydrogel to allow its swollen
and collapse, respectively). Aliquots were removed at differ-
ent time intervals and natamycin amount was determined in
the same way as natamycin released from films in the liquid
medium (see BIn Distilled Water^ section). Three replicates
were evaluated for each temperature.
Solid Medium
GA films with 35 mm diameter were placed on Petri dishes
having the same diameter, which contained 2 mL of agar
(bacteriological European type, Cultimed, Panreac,
Barcelona, Spain) (12 mg mL−1). Then, Petri dishes were
incubated at two different temperatures, 5 and 37 °C, and
55 % RH. At each sampling time, films were removed from
the agar surface using a clamp. Agar samples were then sliced,
frozen and then lyophilised to extract and quantify the
natamycin released from GA films as explained in the section
BIn Agar Plates^. Four replicates of each film were evaluated
for each temperature.
In the same way as in the liquid medium, a control exper-
iment was performed quantifying natamycin availability in
agar plates initially added with an aqueous solution of com-
mercial natamycin to obtain final concentrations in agar from
0.1 to 2.5 μg mL−1, and incubated at 5 and 37 °C and 55 %
RH. Natamycin was extracted and quantified at different time
intervals in the same way as natamycin released from films in
the solid medium (see BIn Agar Plates^ section). Three repli-
cates were evaluated for each temperature.
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Natamycin Quantification
In Distilled Water
The natamycin concentration in the dialysate (distilled water)
was determined spectrophotometrically at 319 nm (Beckman
Coulter Inc., Brea, CA, USA) as described in Fuciños et al.
(2012) by the molar absorption coefficient (ε) calculated for
natamycin (0.077±0.006 mL μg−1 cm−1).
In Agar Plates
Samples with 2 mL of agar media containing the natamycin
released from GA films were sliced, frozen and then
lyophilised. After lyophilisation, samples were embedded in
2 mL of methanol (CHROMASOLV® for HPLC, ≥99.9 %,
v/v, Sigma-Aldrich, Munich, Germany) during 1 h under agi-
tation at 25 °C in order to extract the natamycin without any
additional dilution. Then, samples were filtered (0.45 μm) in
order to remove any remaining agar. In these extracts,
natamycin was quantified by reverse phase high-
performance liquid chromatography (RP-HPLC), following
the method of Roberts et al. (2011), with some modifications.
RP-HPLC was performed using an Agilent 1200 system
(Agilent Technologies, Palo Alto, CA, USA). Separation
was performed employing an ACE® C18 column (4.6 mm×
150 mm, 5 μm) with the column oven kept at 30 °C. The flow
rate was 1.0 mL min−1, the injection volume was 20 μL and
the detection wavelength was 319 nm. Mobile phase A
consisted in Milli-Q water/acetic acid (puriss., p.a. ACS re-
agent, ≥99.8 %, v/v, Sigma-Aldrich, Munich, Germany)
(97:3, v/v) and mobile phase B consisted of methanol/acetic
acid (97:3, v/v). Mobile phase Awas maintained at 90 % (v/v)
for the first 6 min and then decreased linearly to 10 % (v/v)
over 25 min. Finally, mobile phase A was increased to 90 %
(v/v) and the column was re-equilibrated for a further 9 min.
The accuracy of natamycin extraction and quantification by
RP-HPLC was determined by adding 2 mL agar samples with
100 μL of a pure natamycin (≥95 %, w/w, HPLC, Sigma-
Aldrich, Munich, Germany) solution to obtain final concen-
trations in agar from 0.1 to 2.5 μg mL−1. Table 1 shows the
natamycin rate recovery for each concentration tested.
The results of natamycin extraction and detection, shown
in Table 1, are acceptable for natamycin concentrations above
0.25 μg mL−1. This detection limit (DL) was considered suf-
ficient to address the natamycin release assays from the films
with PNIPA/AA nanohydrogels, since minimum inhibitory
concentrations (MIC) of natamycin are usually between 1
and 10 μg mL−1 or even higher for some moulds that, in
general, are less sensitive than yeasts (Stark and Tan 2003;
Delves-Broughton et al. 2010).
Microbial Assay
Strains and Growth Conditions
Stock cultures of Penicillium commune (P 1.01) were grown
on potato dextrose agar (PDA, specific for cultivation of fungi,
DifcoTM, Detroit, MI, USA) acidified to pH 3.5 with 10% (w/
v) L(+)-tartaric acid (Panreac, Barcelona, Spain) at 25 °C and
maintained on slants of this media at 4 °C. The inoculum of
this strain was prepared as explained in Fajardo et al. (2010)
by overlaying mature slants with sterile Tween 80, 0.05 % (w/
v), and gently scraping the surface with a Drigalski spatula.
The mould culture suspensions were filtered through sterile
gauze pads to remove the mycelium, and spore count was
determined using a Neubauer chamber. Necessary dilutions
were made with Tween 80, 0.05 % (w/v), to obtain 106 spores
per mL counts.
Stock cultures of Saccharomyces cerevisiae (Sc 1.02) were
grown in YPD medium (yeast extract 10 g L−1; peptone
20 g L−1; D(+)-glucose 20 g L−1, all from Panreac,
Barcelona, Spain) at 25 °C and maintained at −40 °C in the
same media, supplemented with 15 % (w/w) glycerol (87 %,
v/v, Panreac, Spain). The inoculum was prepared with a 12-h
culture after three steps, containing 26×106 colony-forming
units (CFU)mL−1. Counts were determined by standard plate
count with PDA acidified to pH 3.5 with 10 % (w/v) L(+)-
tartaric acid.
Inhibition Studies Employing a Food Model System
Following the procedure described by Fuciños et al. (2012), a
food model system consisting of Petri dishes with 5 mL of
PDA acidified (pH=3) with 10 % (w/v) L(+)-tartaric acid and
plate storage under fluorescent lighting was used, in order to
simulate unfavourable conditions for the chemical stability of
natamycin. Three replicates of each film, prepared as ex-
plained in BPreparation of Natamycin-Loaded PNIPA/AA
Nanohydrogels Incorporated into κ-Carrageenan and Locust
Bean Gum (GA) Films^, were evaluated.
P. commune (P 1.01) and S. cerevisiae (Sc 1.02) were used
as indicator microorganisms. An aliquot of 25 μL of a 12-h
culture of Sc 1.02 (26×106 CFU mL−1) and 10 μL of P 1.01
(26×106 spores mL−1) was inoculated in triplicate into the
Table 1 Accuracy of the
natamycin extraction and
quantification by RP-
HPLC
Natamycin
concentration in agar
plates (μg mL−1)
% Accuracy
2.50 78.80±2.83
1.00 79.00±1.41
0.50 96.00±11.31
0.25 120.00±11.31
0.10 207.00±18.38
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Petri dishes. After 1 h in the fridge to allow the inoculated
culture to be absorbed properly, films (GA, GA+NA(564),
GA+NA(8), GA-PNIPA(5)+NA(8) and GA-PNIPA-
20AA(5)+NA(8)) were placed covering the entire surface of
the Petri dishes. All plates were incubated at 5 °C for 3 days
and then at 37 °C, until the end of the experiment (8 days).
Data Fitting and Statistical Analyses
Student’s t test (α=0.05) was used to analyse differences be-
tween two samples for a single variable. One-way analysis of
variance (ANOVA) followed by Tukey post-tests was per-
formed for multiple comparisons. Both analyses were per-
formed by using GraphPad PrismTM 5 (GraphPad Software
Inc., San Diego, CA, USA).
Plotting was also performed by using GraphPad PrismTM
5. Data fitting, parametric estimation and significance tests,
both for parameters and models, were performed with
SigmaPlot 11.0 (Systat Software, Inc. San Jose, CA, USA).
Results and Discussion
Natamycin Release from PNIPA/AA Nanohydrogels
Incorporated into GA Films
Initially, natamycin diffusion from films to a liquid (distilled
water) or solid medium (agar) was evaluated to determine the
maximum release efficiency of the active compound from the
system according to the application.
Liquid Medium
Taking into account that the natamycin release, during the
dialysis process, will stop when the equilibrium concentration
is reached, not all the natamycin loaded into the films could be
recovered in the dialysis medium. That is why it has been
considered that the maximum amount of natamycin released
from the films is the amount of natamycin released in dialysis
experiments carried out with free natamycin (Fuciños et al.
2014b). The relative fraction of natamycin released (γFt) is
defined by the following expression:
γFt ¼ Ct GA‐NACmax NA ð1Þ
whereCt GA-NA is the amount of natamycin (μg) released from
the film to the dialysis medium (passing through the dialysis
membrane) and Cmax NA is the amount of natamycin (μg)
under the steady-state conditions determined in the dialysis
experiments with free natamycin (without film) for a given
temperature. The amount of natamycin released through the
dialysis membrane was not affected by temperature (data not
shown) and was calculated with the equation developed in
Fuciños et al. (2014b):
Ct ¼ Cmax þ C0  Cmaxð Þe
m 1þ
Xk
i¼1
βi ⋅X i
 !
t
ð2Þ
where Ct is the concentration of the natamycin released
(μg mL−1) at time t (min), C0 is the initial natamycin concen-
tration in the medium (μg mL−1), Cmax is the maximum
achievable concentration of the released natamycin
(μg mL−1), m is the maximum achievable release rate of
natamycin (min−1), k is the number of variables involved in
a particular release system, βi is the coefficient which influ-
ences the m and reflects the linear effect and Xi represents the
independent variable (temperature).
Figure 1 shows the natamycin release profiles obtained
from GA films. The two most characteristic features of the
natamycin release from GA films containing PNIPA/AA
nanohydrogels (GA-PNIPA(5) and GA-PNIPA-20AA(5))
were that the release was controlled by the temperature and
the kinetic shape was not hyperbolic, as expected from a sim-
ple diffusion process such as that observed for GA-NA cases
(Fig. 1a, b). The lag time in Fig. 1c, d corresponds to the
beginning of natamycin release. In addition, it seems that the
temperature influences natamycin release from GA films,
which increased when natamycin was incorporated into GA
films by encapsulation into PNIPA/AA nanohydrogels (ex-
plained by the nanohydrogel collapse when the temperature
rises above its lower critical solution temperature). This re-
stricts natamycin release when the temperature is increased,
i.e. when there is a risk of contamination/growth of microor-
ganisms that cause food spoilage or the development of path-
ogenic microorganisms.
For a better analysis, experimental data were fitted with the
reparametrised logistic model proposed by Vázquez et al.
(2008) to make explicit the lag time:
γFt ¼ γFmax
1þ e2þ4 ⋅vmaxγ Fmax λ−tð Þ
ð3Þ
where γFmax is the maximum relative fraction of natamycin
released from the GA films through the dialysis membrane,
vmax is the maximum release rate (h
−1) and λ and t are the lag
time for the natamycin release and the sampling time, respec-
tively, both expressed in hours (h).
Equation 3 provided a good fit of the experimental data and
the parameters generated are shown in Table 2. Natamycin re-
lease from GA films when it was not nanoencapsulated (GA-
NA(564)) appears to be governed only by molecular diffusion
and by the polymer relaxation, as presented by Fajardo et al.
(2010), and both phenomena will be influenced by temperature
increase. The early time release data (~60 %) of the natamycin
release from the GA films studied were also fitted with the
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following well-known mathematical model (Ahuja et al. 2007;
Blanco et al. 2008; Fuciños et al. 2014b):
γFt ¼ k ⋅tn ð4Þ
where γFt is the relative fraction of natamycin released at
time t, k is a release kinetic constant that depends on the
biomolecule-polymer system characteristics and n is the
diffusional exponent that depends on both the geometry of
the delivery system and the physical mechanisms in-
volved (Ritger and Peppas 1987). Thus, according to the
n value, the release from a thin film can be catalogued
into one of the following diffusion mechanisms
(Siepmann and Siepmann 2008):
– n=0.5: Fickian diffusion (Case I). Biomolecule release is
controlled only by diffusion into the release medium.
– n=1: Case II transport. Biomolecule release is controlled
by the polymer swelling and relaxation mechanism.
– 0.5<n<1: Non-Fickian transport or anomalous transport.
Biomolecule release is controlled by both mechanisms.
The values of diffusion exponent n were 0.80±0.04 and
0.66±0.04 for natamycin release from GA film (GA-
NA(564)) at 10 and 37 °C, respectively, indicating that
natamycin release from GA films was governed by polymer
relaxation and natamycin diffusion into the release medium.
The differences between these values are not significant
(p>0.05). However, due to the increase of the polymer relax-
ation rate with increasing temperatures (Bourbon et al. 2010),
the natamycin release is favoured when temperature increases
from 10 to 37 °C, showing significant (p<0.05) differences in
the values of vmax and γFmax (Table 2).
Fig. 1 Variation of the relative
fraction of natamycin released
(γF) with time from GA films
loaded with free natamycin: GA+
NA(564) and GA+NA(8) (a and
b, respectively); and natamycin
encapsulated into PNIPA/AA
nanohydrogels: GA-PNIPA(5)+
NA(8) and GA-PNIPA-
20AA(5)+NA(8) (c, d), through a
3500-g-mol−1 cut-off dialysis
membrane in distilled water at
10 °C (empty circle) and 37 °C
(filled circle). The lines are the
fitting curves generated from
Eq. 3
Table 2 Natamycin release parameters from different GA films and temperatures, calculated with Eq. 3, in liquid medium
Film T (°C) γFmax vmax (h
−1) λ (h) r2
GA-NA(564) 10 0.841±0.027a, α 0.021±0.002a, α 2.941±2.326n.s., a, α 0.9716
37 1.024±0.028b, α 0.035±0.004b, α −0.032±1.576n.s., a, α 0.9712
GA+NA(8) 10 0.218±0.014a, β 0.021±0.011n.s., a, α 2.735±2.048n.s., a, α 0.8348
37 0.209±0.011a, β 0.023±0.006a, α −0.145±1.093n.s., a, α 0.8765
GA-PNIPA(5)+NA(8) 10 – – – –
37 1.084±0.040α 0.034±0.005α 32.914±2.797β 0.9798
GA-PNIPA-20AA(5)+NA(8) 10 – – – –
37 0.582±0.142γ 0.005±0.001β 35.438±12.942β 0.8364
Values reported are the means±standard deviation (n=2). a, b: statistically significant differences (p<0.05) between different temperatures for the same
film; α, β, γ: statistically significant differences (p<0.05) between different films for the same temperature
n.s. parameter not significant (p>0.05)
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Unlike GA-NA(564) films, when the concentration of
natamycin was reduced to the same values as in the films with
nanohydrogels (GA+NA(8)), it was not possible to extract all
the natamycin loaded. This could be explained by a fixed amount
of natamycin that always remains trapped in the films, for all the
tested natamycin concentrations (Fig. 2). Contrary, if the initial
amount of natamycin is very high, the fraction of natamycin
remaining entrapped is imperceptible. Around 75 % (w/w) of
the natamycin initially charged remained trapped in the GA+
NA(8) film. However, this amount only accounts for around
1% (w/w) of the natamycin charged into the GA+NA(564) film.
The values of the diffusion exponent n for GA+NA(8) film
were 0.75±0.34 and 0.62±0.23, at 10 and 37 °C, respectively.
In the same manner as for the GA+NA(564) films, there were
no significant (p>0.05) differences between the n values at
both temperatures assayed, showing that natamycin release
from the films was governed by the polymer relaxation and
natamycin diffusion into the release medium.
As mentioned above, the effect of temperature in
natamycin release is more obvious when the natamycin is
loaded into PNIPA/AA nanohydrogels and then incorporated
into GA films. At 10 °C, the release practically did not occur
for both nanohydrogels assayed (Fig. 1), and for that reason, it
was not possible to fit the experimental data (Table 2). The
release was increased when the temperature was raised to
37 °C. These results are consistent with PNIPA behaviour,
widely described in literature (Zhang et al. 2002; Huang and
Lowe 2005; Fuciños et al. 2014a), where it is shown that when
the temperature increases above the LCST, at ca. 33 °C, hy-
drophobic interactions amongst PNIPA chains strengthen dra-
matically, leading to the collapse of the hydrogel and, conse-
quently, to the release of the biomolecule.
The γFmax value for the natamycin release at 37 °C from
GA-PNIPA(5)+NA(8) films was approximately 2-fold
(p<0.05) the value for the natamycin release from GA-
PNIPA-20AA(5)+NA(8) films (Table 2). In addition, the vmax
value was statistically different (p<0.05) for both films with
nanohydrogels. However, the vmax value for the GA-
PNIPA(5)+NA(8) films was not statistically different
(p<0.05) from films with free natamycin (i.e. GA-NA(564)
and GA+NA(8)) (Table 2). This could be explained by the
natamycin location near the surface or on the surface of
nanohydrogel particles in the case of the nanohydrogel without
AA (PNIPA(5)); when the collapse occurs at 37 °C, a fast
release of natamycin occurs, leading to the burst effect
(Fig. 1c). In contrast, natamycin could be more included into
the most hydrophilic nanohydrogel matrix (PNIPA-20AA(5)).
This behaviour is consistent with the results shown in Fuciños
et al. (2012, 2014b), where it has been shown that when the
nanoparticle collapses (with the increase of temperature),
natamycin is released from inside the polymer matrix at a
slower rate than when it remained near the polymer surface,
justifying the slower and continuous release of natamycin from
GA-PNIPA-20AA(5) films. The intense collapse, which oc-
curred in GA-PNIPA(5) films when temperature increased, re-
sulted in a rapid increase of natamycin release leading to a
higher γFmax value (Table 2) than that obtained with GA-
PNIPA-20AA(5) films, despite the release having stopped ear-
lier (Fig. 1).
As explained before, there is a clear difference between the
kinetic release of natamycin from GA films with and without
nanohydrogels (Fig. 1). This fact was reflected in the statisti-
cal (p<0.05) differences between their lag times (Table 2),
increasing from values close to 0 h (i.e. the natamycin release
began immediately) to values around 35 h when natamycin is
added to the films loaded in the nanohydrogels. There were no
significant differences between the lag time (λ) with GA+
NA(564) and GA+NA(8), and also there were no significant
(p>0.05) differences between the values of λ with GA-
PNIPA(5)+NA(8) and GA-PNIPA-20AA(5)+NA(8). In
Fuciños et al. (2014a), results showed that in a basic release
Fig. 2 Scheme of hypothetical behaviours to natamycin release, from
different polymeric matrix, after a temperature rise
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medium (pH>pKa of AA), it is difficult to find differences
between the LCST value for the nanohydrogels with and with-
out AA due to the presence of ionised –COO− groups, which
prevent the collapse of nanohydrogels with AA. So, it is not
strange that natamycin release due to the collapse of the
nanohydrogel begins at the same time for both nanohydrogels,
with and without AA, despite the more hydrophilic
nanohydrogel collapse being less intense.
Finally, it is important to mention that the encapsulation of
natamycin into nanohydrogels to be included into the GA
films seems to help natamycin to be released when it was
included in low quantities, since γFmax with GA-PNIPA(5)+
NA(8) and GA-PNIPA-20AA(5)+NA(8) was significantly
(p<0.05) higher than γFmax with GA+NA(8), at 37 °C. This
behaviour can be explained by the scheme presented in Fig. 2,
where the location of nanohydrogel particles near the film
surface could favour natamycin release from films. Scanning
electron microscopy (SEM) images of these films containing
nanohydrogels, shown in a previous work (Cerqueira et al.
2014), seem to confirm the location of nanoparticles at the
surface of films. So the encapsulation of natamycin into
nanohydrogels (GA-PNIPA(5)+NA(8) and GA-PNIPA-
20AA(5)+NA(8)) allows for a more concentrated pres-
ence of natamycin at certain points of the matrix (i.e.
surface) compared to natamycin incorporated alone into
the films (GA+NA(8)), facilitating natamycin diffusion
from film matrix.
Solid Medium
In order to evaluate the amount of natamycin released from
GA films with a different composition into a solid medium,
i.e. agar, the fraction of natamycin released (Ft) was calculated
as the amount of natamycin extracted from the agar samples
(as explained in BIn Agar Plates^), in relation with the total
amount of natamycin initially added to the film. Table 3 shows
the Ft values from different GA films and temperatures.
Lower fractions of natamycin were released to agar plates
as the diffusion process in a solid medium is indeed far more
complex than in a simple liquid medium. However, the release
study in this matrix could provide a more realistic evaluation
of the diffusion process in a food matrix.
In the same manner as in the liquid medium, the natamycin
release from GA-NA(564) films increased and stabilised quickly
for both temperatures (Table 3). However, in general, the Ft
values in the solid medium were statistically (p<0.05) lower
when temperature is increased to 37 °C, so it seems that
natamycin release from these films was lower at higher temper-
atures, contrary to the results observed in a liquid medium. The
behaviour was similar for the natamycin release from GA+
NA(8) films; however, the differences are not statistically signif-
icant (p>0.05). In general, as in the liquid medium, lower Ft
values were obtained from this film compared with those Ft
values obtainedwithGA films initially loadedwith high amounts
of natamycin (Table 3).
Regarding natamycin release from PNIPA/AA
nanohydrogels embedded into GA films, in general, Ft values
with GA-PNIPA(5)+NA(8) films were significantly (p<0.05)
higher than those obtained with GA-PNIPA-20AA(5)+NA(8)
films, and as explained for the release kinetics in the liquid
medium, this was probably due to a higher exposure of
natamycin near the surface of nanohydrogel particles, as was
concluded by Fuciños et al. (2012, 2014b). Nevertheless, in
contrast to what happened in the liquid medium, it seems that
the release only occurred at 5 °C.
A control experiment was performed to check the availabil-
ity of natamycin, both in distilled water (liquid medium) and
agar plates (solid medium), during the storage time at temper-
atures used in natamycin release experiments. The results ob-
tained (data not shown) indicate that the degradation or entrap-
ment of natamycin in agar is not enough to explain the low
natamycin release from films at 37 °C. There were no signifi-
cant (p>0.05) differences of natamycin concentration between
samples stored at 10 and 37 °C in water. And although signif-
icant (p<0.05) differences appeared between samples stored at
10 and 37 °C, differences only appeared over prolonged pe-
riods of time, in the experiment of natamycin availability in
agar. However, low natamycin values were observed from 1 h
of storage at 37 °C (Table 3), in the experiments of natamycin
release from films in agar. Therefore, the low water availability
in the solid medium was proposed as the main cause of low
natamycin release, slowing its diffusion from films. On the one
hand, the absence of water reduces polymer relaxation, and
therefore, the on/off release mechanism of PNIPA
nanohydrogels could be limited; on the other hand, the absence
of water at high temperatures could favour the formation of
hydrophobic interactions between natamycin and polymer
chains, as noted in Fuciños et al. (2014b) to explain a great
natamycin entrapment in PNIPA nanohydrogels when the
nanoparticles expelled the water contained in them.
Antimicrobial Efficiency of Natamycin-Loaded PNIP
A/AA Nanohydrogels Incorporated into GA Films
In Fuciños et al. (2012), the protection capacity of PNIPA/
AA nanohydrogels has been demonstrated, which allowed
natamycin to remain active under conditions that were
unfavourable for its chemical stability, thus improving its
antimicrobial effect. That is why, in this work, we also
evaluated the antimicrobial effectiveness of GA films con-
taining natamycin-loaded nanohydrogels under the same
unfavourable conditions for natamycin stability employed
in Fuciños et al. (2012), i.e. acidified PDA plates and fluo-
rescent lighting.
In plates inoculated with the indicator mould (P
1.01), growth appears to be limited by the coating itself,
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since there is virtually no growth throughout the storage
time and there were no noticeable differences between
films with the antimicrobial treatments and controls
(Fig. 3).
The plates inoculated with the indicator yeast (Sc 1.02)
provide more revealing results that are consistent with the
results observed in the release experiments into a solid medi-
um (see BSolid Medium^). So, no growth was observed at
Fig. 3 Inhibition of Saccharomyces cerevisiae (Sc 1.02) and Penicillium commune (P 1.01) in acidified PDA agar plates by treatment with different GA
films, under fluorescent lighting in order to simulate unfavourable conditions for the chemical stability of natamycin
Table 3 Fraction of natamycin released (Ft) from different GA films and temperatures in solid medium
Storage time (h) T (°C) Film
GA+NA(564) GA+NA(8) GA-PNIPA(5)+NA(8) GA-PNIPA-20AA(5)+NA(8)
1 5 0.029±0.006a, α 0.025±0.016a, α 0.053±0.015a, β < DL
37 0.049±0.011b, α 0.009±0.013a, β < DL < DL
2 5 0.068±0.015a, α 0.025±0.029a, α, β 0.071±0.033a, α < DL
37 0.038±0.008b, α 0.020±0.023a, α, β < DL < DL
4 5 0.045±0.009a, α 0.029±0.035a, α, β 0.058±0.012a, α < DL
37 0.049±0.012a, α 0.006±0.011a, β < DL < DL
8 5 0.057±0.007a, α < DL 0.036±0.012a, γ < DL
37 0.033±0.003b, α 0.008±0.015a, β < DL < DL
22 5 0.069±0.013a, α 0.027±0.053a, α, β 0.040±0.014a, α, β < DL
37 0.034±0.009b, α 0.008±0.016a, α < DL 0.015±0.029a, α
30 5 0.068±0.007a, α 0.102±0.013a, β 0.058±0.018a, α < DL
37 0.044±0.010b, α 0.042±0.031b, α < DL < DL
46 5 0.060±0.013a, α 0.014±0.028a, β 0.060±0.012a, α < DL
37 0.023±0.008b, α < DL < DL < DL
70 5 0.046±0.012a, α 0.015±0.018a, β < DL < DL
37 0.031±0.016a, α 0.008±0.016a, α, β < DL < DL
Values reported are the means±standard deviation (n=4). a, b: statistically significant differences (p<0.05) between different temperatures for the same
film; α, β, γ: statistically significant differences (p<0.05) between different films for the same temperature
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5 °C and growth peaked rapidly when the temperature in-
creased up to 37 °C in control plates treated with GA films
without natamycin (GA) (Fig. 3). In plates treated with films
that have the highest natamycin content (GA-NA(564)), inhi-
bition was maintained until the end of the assay (8 days). By
contrast, higher growth was observed in those plates treated
with GA-PNIPA-20AA(5)+NA(8) films, according to the
lower natamycin release observed from these films to agar
plates (Table 3). Growth observed with the GA-PNIPA(5)+
NA(8) and GA+NA(8) films was less intense, when com-
pared with GA-PNIPA-20AA(5)+NA(8) films, especially
for the first one (Fig. 3). Results showed plates with large
inhibition zones when these were treated with GA-
PNIPA(5)+NA(8) films when compared with those plates
treated with GA and GA+NA(8) films. These differences
could be due to the protection of natamycin against degrada-
tion conditions, i.e. under acidic conditions (Stark and Tan
2003) and fluorescent lighting (Koontz et al. 2003), when it
was included into the nanohydrogels allowing its release only
when the temperature increased (Fuciños et al. 2012). This
makes it possible to maintain the inhibition for more days.
Conclusions
In view of the results observed in both systems—liquid and
solid medium—it is necessary to continue working to improve
the amount of natamycin released from the new smart films
where it seems that the PNIPA/AA nanohydrogel swelling/
collapse is limited once it was trapped into the GA films. In
any case, this system makes it possible to reduce natamycin
concentrations in food products whilst improving the antifun-
gal effect in terms of that observed when natamycin was in-
cluded alone in the GA film, by the same amount. We noted
promising results that demonstrate the potential of
polysaccharide-based films containing smart nanohydrogels
for the controlled release of food preservatives.
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